XinTong Medical-B (02160): Brian Chang appointed as non-executive director and co-chairman of the board

Zhitong Finance App News, Xintong Medical-B (02160) issued an announcement. Starting from December 15, 2025, Mr. Zhao Liang and Ms. Yan Luying will resign as executive directors due to their intention to invest more time in the Group's management affairs; and Mr. Zhang Junjie will resign as a non-executive director due to personal work arrangements. Dr. Brian Chang has been appointed as a non-executive director and co-chairman of the board of directors; Mr. Philippe Wanstok has been appointed as the company's executive director and vice president; and Mr. Deng Aoyi has been appointed as a non-executive director with effect from December 15, 2025.

Furthermore, in order to better reflect the control relationship between Minimally Invasive Medical Science Co., Ltd., the controlling shareholder of the company, and also consistent with the commercial names “MicroPort CardioFlow” and “Minimally Invasive Heart” currently used by the company in sales and marketing activities and all daily operations, the English stock abbreviation for shares traded on the Stock Exchange was changed from “CARDIOFLOW-B” to “MP CARDIOFLOW-B”, and the Chinese stock abbreviation was changed from “Xintong Medical-B” to “Minimally Invasive Heart-B” from 2025 It will take effect at 9:00 a.m. on December 22. The company's English and Chinese names are still “MicroPort CardioFlow Medtech Corporation” and “Minimally Invasive Xintong Medical Technology Co., Ltd.”, respectively, and the company's stock code on the Stock Exchange is still “2160.”